戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ge from 0 (no activity) to 1 (bioactivity of 17beta-estradiol).
2 emale immunodeficient mice supplemented with 17beta-estradiol.
3 estrogen receptor alpha (ERalpha) to that of 17beta-estradiol.
4 t of ERalpha-AF2 in the metabolic actions of 17beta-estradiol.
5 ignaling mechanisms from ERalpha, ERbeta, or 17beta-estradiol.
6 rs (ER) are activated by the steroid hormone 17beta-estradiol.
7 M site for steroid hormone estrogens such as 17beta-estradiol.
8 indicate that this transporter is induced by 17beta-estradiol.
9 oved growth of xenografts in the presence of 17beta-Estradiol.
10 ESR1) in the presence of its cognate ligand, 17beta-estradiol.
11 onal regulation of the SNAT2 transporter via 17beta-estradiol.
12 , and its protective effect is stronger than 17beta-estradiol.
13 ment for NO/cGMP/PKG signaling downstream of 17beta-estradiol.
14 enotype by antagonizing the growth effect of 17beta-estradiol.
15 y prevented when cells were pre-treated with 17beta-estradiol.
16 apeutic effect of post-SCI administration of 17beta-estradiol.
17 (ER) alpha and beta differ from that used by 17beta-estradiol.
18  aptamer, which highly specifically binds to 17beta-estradiol.
19 nted conductive polymer-coated electrodes to 17beta-estradiol.
20 aring CIN lesions were treated with MPA plus 17beta-estradiol.
21 eported 35-mer aptamer for a small molecule, 17beta-estradiol.
22  wine samples, as well as cocaine (1 nM) and 17beta-estradiol (0.2 nM) in spiked synthetic urine and
23  were 0.045 ng/L for estrone, 0.086 ng/L for 17beta-estradiol, 0.030 ng/L for estriol, 0.049 ng/L for
24 ere randomly assigned to receive either oral 17beta-estradiol (1 mg per day, plus progesterone [45 mg
25 al, as shown by vesicular transport of [(3)H]17beta-estradiol-17-beta-(D-glucuronide) and doxorubicin
26 sformation of two natural steroid estrogens [17beta-estradiol (17beta-E2) and estrone (E1)] and two s
27 ne hormones, 17alpha-estradiol (17alpha-E2), 17beta-estradiol (17beta-E2), and estrone (E1), are rout
28                                  Addition of 17beta-estradiol (17betaE2) protected cultured neurons a
29  PET with the ER ligand 16alpha-(18)F-fluoro-17beta-estradiol ((18)F-FES) and to evaluate whether tra
30                         16alpha-(18)F-fluoro-17beta-estradiol ((18)F-FES) is a PET tracer for ER with
31                         16alpha-(18)F-fluoro-17beta-estradiol ((18)F-FES) is an estrogen receptor (ER
32 ression with the tracer 16alpha-(18)F-fluoro-17beta-estradiol ((18)F-FES) may be valuable to select o
33                         16alpha-(18)F-fluoro-17beta-estradiol ((18)F-FES) with PET is a noninvasive t
34 reated for 5 weeks with cyclic injections of 17beta-estradiol-3-benzoate (EB, 10 mug) or oil vehicle.
35 ed with a (14)C labeled prototype conjugate, 17beta-estradiol-3-glucuronide (E2-3G).
36 emical transformation from parent compounds (17beta-estradiol, 4-nonylphenolpolyethoxylates, and 4-no
37                                 Accordingly, 17beta-estradiol administration regulated key metabolic
38 lso exerts a stronger protective effect than 17beta-estradiol against kanic acid-induced hippocampal
39 ently found that the protection conferred by 17beta-estradiol against obesity and insulin resistance
40 recursor prodrug of the main human estrogen, 17beta-estradiol, alleviates hot flushes in rat models o
41             Unlike control mice treated with 17beta-estradiol alone, cervical cancer was absent in th
42  sensitive and highly selective detection of 17beta-estradiol, an EDC that is frequently detected in
43 n, some methods reported false positives for 17beta-estradiol and 17alpha-ethynylestradiol in unspike
44 In these studies, we assessed the ability of 17beta-estradiol and equol to regulate markers of hippoc
45                                   Similarly, 17beta-estradiol and equol treatment had no effect on mi
46 endocrine-disrupting chemicals, particularly 17beta-estradiol and estrone, and fish exposed to the po
47                     These data indicate that 17beta-estradiol and GPER independently regulate hippoca
48                                              17beta-estradiol and IL-6 may act synergistically to pro
49 hondrial damage using synergistic effects of 17beta-estradiol and methylene blue, previously shown by
50                       Chronic treatment with 17beta-estradiol and tamoxifen elicited differential gen
51      Here we show that physiologic estrogen (17beta-estradiol) and progesterone reciprocally regulate
52 nts were respectively theophylline, digoxin, 17beta-estradiol, and aldrin.
53        In WTP influents, estrogens (estrone, 17beta-estradiol, and estriol), androgens (androstenedio
54 ted the fate and transport of 4-nonylphenol, 17beta-estradiol, and estrone in a 10-km reach of the Re
55 ural estrogenic hormones (17alpha-estradiol, 17beta-estradiol, and estrone) in aqueous solutions blen
56 of the initial amounts of 17alpha-estradiol, 17beta-estradiol, and estrone, respectively.
57 tain florfenicol, pyrimethamine, estrone and 17beta-estradiol at levels from 0.095 to 2.7 mug/kg.
58 anure excreted by implanted (40 mg TBA, 8 mg 17beta-estradiol) beef cattle.
59 n terms of research and monitoring have been 17beta-estradiol (beta-E2) and 17alpha-ethinylestradiol,
60 f Fe(3+)-saturated montmorillonite catalyzed 17beta-estradiol (betaE2) transformation was investigate
61 he alpha4beta2-selective positive modulators 17beta-estradiol (betaEST) and desformylflustrabromine (
62                                      BPA and 17beta-estradiol bind to ERs in a similar fashion, where
63    This effect was associated with increased 17beta-estradiol but not with insulin-like growth factor
64        UM-SCC-11A and UM-SCC-12 both produce 17beta-estradiol, but only UM-SCC-12, not UM-SCC-11A, xe
65                          Across women, lower 17beta-estradiol concentrations were related to more pro
66 creened eel serum samples to determine their 17beta-estradiol concentrations, which were found to be
67                                              17beta-estradiol-D5 was used as internal standard.
68     We found that post-SCI administration of 17beta-estradiol decreased neuronal loss in the ventral
69                     Neutrophils treated with 17beta-estradiol demonstrated an enhanced oxidative burs
70 that in human breast cancer cells, the acute 17beta-estradiol-dependent activation of functional enha
71 yo implantation is coordinately regulated by 17beta-estradiol (E(2)) and progesterone (P(4)).
72                               We report that 17beta-estradiol (E(2)) decreased osteoclast number by p
73 as safer estrogenic candidates compared with 17beta-estradiol (E(2)) for the treatment of endocrine-r
74 l studies indicates that the gonadal hormone 17beta-estradiol (E(2)) impacts the structure and functi
75 agonist G-1 mimics the beneficial effects of 17beta-estradiol (E(2)) on hippocampal CA1 spine density
76  (PKC) signaling can be activated rapidly by 17beta-estradiol (E(2)) via nontraditional signaling in
77 ablation blocked the reduction of T(SKIN) by 17beta-estradiol (E(2)), which occurred in the environme
78                                              17beta-Estradiol (E(2))-mediated ER activation stabilize
79  in part owing to a reduction in circulating 17beta-estradiol (E(2)).
80 plex by different types of estrogens-planar [17beta-estradiol (E(2))] and angular triphenylethylene (
81 nal epithelium were treated with either 4 nM 17beta-estradiol (E) for seven days, 50 ng/ml E.coli fla
82 -enhancing effects of the modulatory hormone 17beta-estradiol E2.
83                                              17beta-estradiol (E2 or estrogen) is an endogenous stero
84 mug L(-1)), while that of the native hormone 17beta-estradiol (E2) (1 muM, i.e., 272 mug L(-1)) was 1
85 alpha-containing cancer cells, the estrogen, 17beta-estradiol (E2) activates the UPR through a phosph
86                       We found recently that 17beta-estradiol (E2) acutely suppresses GABAergic inhib
87                               We report that 17beta-estradiol (E2) affects the behavior and the epige
88                                              17beta-estradiol (E2) also influences hypothalamic progr
89  fluctuations and systemic administration of 17beta-estradiol (E2) alter spine density in the dorsal
90 s often found in treated and natural waters, 17beta-estradiol (E2) and 17alpha-ethynylestradiol (EE).
91     The response of ovariectomized adults to 17beta-estradiol (E2) and artificial decidualization wer
92             We investigated the potential of 17beta-estradiol (E2) and estrogen receptor (ER) signali
93 ch were transformed into the free estrogens, 17beta-estradiol (E2) and estrone (E1), respectively.
94 owever, few studies have assessed both serum 17beta-estradiol (E2) and exogenous hormone therapy (HT)
95 to analogues similar to progesterone such as 17beta-estradiol (E2) and norethisterone (NET).
96 e sought to Determine the mechanism by which 17beta-estradiol (E2) and progesterone (P4) increase IL-
97                         We demonstrated that 17beta-estradiol (E2) and the GPER-selective ligand G-1
98 tudy, we demonstrate for the first time that 17beta-estradiol (E2) and the selective GPER ligand G-1
99               The neuroprotective effects of 17beta-estradiol (E2) and three synthetic nonfeminizing
100 nse-response relationships describing plasma 17beta-estradiol (E2) as a function of plasma fadrozole,
101 ator of an inflammatory microenvironment and 17beta-Estradiol (E2) as an agonist of Estrogen Receptor
102  using thyroid stimulating hormone (TSH) and 17beta-estradiol (E2) as model analytes, respectively.
103 -ethylbenzthiazoline-6-sulfonate) (ABTS) and 17beta-estradiol (E2) as the probing substrates.
104                  We previously observed that 17beta-estradiol (E2) augments ischemic borderzone vascu
105  study examined whether the steroid hormone, 17beta-estradiol (E2) can exert long-lasting beneficial
106 this study was to investigate if exposure to 17beta-estradiol (E2) causes abnormal development in lar
107 to affect TMJ-responsive neurons, we applied 17beta-estradiol (E2) directly at the spinomedullary (Vc
108             Exposure of zebrafish embryos to 17beta-estradiol (E2) during liver development significa
109         Our laboratory has demonstrated that 17beta-estradiol (E2) enhances hippocampal memory consol
110 monstrated by an immunospecific detection of 17beta-Estradiol (E2) following the competitive inhibiti
111 ensor for the rapid, label-free detection of 17beta-estradiol (E2) from femtomolar to micromolar leve
112                             Although chronic 17beta-estradiol (E2) has been shown to be a cognition-p
113                                              17beta-Estradiol (E2) has been shown to regulate GM-CSF-
114                                              17beta-estradiol (E2) has broad tropism within the CNS,
115                                  The hormone 17beta-estradiol (E2) has shown vascular protective effe
116 e molecular and cellular mechanisms by which 17beta-estradiol (E2) impacts the microenvironment and m
117  Suwannee River NOM-sensitized photolysis of 17beta-estradiol (E2) in freshwater and saline media.
118 ptor alpha (ERalpha) mediates the effects of 17beta-estradiol (E2) in normal mammary gland, and it is
119 ing ultrasensitive colorimetric detection of 17beta-estradiol (E2) in water and urine samples using D
120                                  Exposure to 17beta-estradiol (E2) increased proliferation of hepatoc
121               Although systemically injected 17beta-estradiol (E2) increases CA1 dendritic spine dens
122 Intriguingly, recent reports have shown that 17beta-estradiol (E2) induces Noxa expression, although
123                         Here, we report that 17beta-estradiol (E2) influences production of runx1+ HS
124                                     We found 17beta-estradiol (E2) inhibited hepatic gluconeogenic ge
125                 Previously, we reported that 17beta-estradiol (E2) inhibits azoxymethane/dextran sulf
126    The uterotropic response of the uterus to 17beta-estradiol (E2) is genetically controlled, with ma
127 pressed during estrous cycle stages in which 17beta-estradiol (E2) is naturally high (e.g., proestrus
128 process by demonstrating that neuron-derived 17beta-estradiol (E2) is neuroprotective and critical fo
129                                              17beta-Estradiol (E2) is produced from androgens via the
130                                  The steroid 17beta-estradiol (E2) is well known to influence hippoca
131  of BSEP was inversely correlated with serum 17beta-estradiol (E2) levels before, during, and after g
132                          In cystic fibrosis, 17beta-estradiol (E2) may inhibit store-operated Ca(2+)
133                                 The estrogen 17beta-estradiol (E2) modulates dendritic spine plastici
134       This study investigated the effects of 17beta-estradiol (E2) on gene regulation in human cardia
135                                The effect of 17beta-estradiol (E2) on IL-13-induced signaling pathway
136 fed high-fat diet (HFD) that received either 17beta-Estradiol (E2) or vehicle implants.
137 t stimulation of ERalpha-positive cells with 17beta-estradiol (E2) promotes global citrullination of
138 ive and positive feedback effects of ovarian 17beta-estradiol (E2) regulating release of gonadotropin
139 d subsequently explored the distribution and 17beta-estradiol (E2) regulation of kisspeptin mRNA (Kis
140                           Given that chronic 17beta-estradiol (E2) replacement of ovariectomized rats
141                     We previously found that 17beta-estradiol (E2) stimulates apolipoprotein A-IV (ap
142                               Treatment with 17beta-estradiol (E2) synergized with DAC to reduce prol
143                            Expression of the 17beta-estradiol (E2) synthesis enzyme aromatase is high
144                               The ability of 17beta-estradiol (E2) to enhance hippocampal object reco
145             We have previously reported that 17beta-estradiol (E2) treatment activates Notch signalin
146 f rodents, and this reduction is reversed by 17beta-estradiol (E2) treatment in a model of human estr
147                                              17beta-Estradiol (E2) treatment limits the pathology ass
148                            Here we show that 17beta-estradiol (E2) up-regulates total CaM level in en
149 (s) of D3 action and compare it with that of 17beta-estradiol (E2) using both in vitro and in vivo ut
150 ductase (5alpha-R) or to the active estrogen 17beta-estradiol (E2) via the aromatase enzyme.
151  An aptamer capable of binding to our target 17beta-estradiol (E2) was isolated by SELEX with dissoci
152                         The classic estrogen 17beta-estradiol (E2) was recently identified as a novel
153  After 2 weeks of exposure, levels of plasma 17beta-estradiol (E2) were significantly elevated in hig
154 gned and synthesized nine new derivatives of 17beta-estradiol (E2) with a bulky side chain attached t
155                                              17beta-estradiol (E2), acting through ERalpha, and pro-i
156 tes express the enzyme aromatase and produce 17beta-estradiol (E2), although the precise role of astr
157 case for the transformation of estrone (E1), 17beta-estradiol (E2), and 17alpha-ethinylestradiol (EE2
158 maceuticals, 17alpha-ethinylestradiol (EE2), 17beta-estradiol (E2), and diclofenac throughout Europea
159 t ovarian sex-steroid hormones, particularly 17beta-estradiol (E2), are important trophic factors tha
160                      Estrogens, particularly 17beta-estradiol (E2), are powerful neuroprotective agen
161 l cells, DNA damage following treatment with 17beta-estradiol (E2), BP-3, and PP was determined by im
162 AROM), the enzyme converting testosterone to 17beta-estradiol (E2), contributes to the regulation of
163  G protein-coupled receptor reported to bind 17beta-estradiol (E2), couple to the G proteins Gs and G
164 termination of four estrogens [estrone (E1), 17beta-estradiol (E2), estriol (E3), and 17alpha-ethinyl
165                                    Estrogen, 17beta-estradiol (E2), is a powerful therapeutic agent t
166 iated by chemical neuromodulators, including 17beta-estradiol (E2), or patterns of synaptic activatio
167 epithelial cells (NHBE) were pretreated with 17beta-estradiol (E2), propyl-pyrazole-triol (PPT, ER-al
168 tablished, recipients were supplemented with 17beta-estradiol (E2), tamoxifen, or left untreated.
169  derivatizaton dehyroepiandrosterone (DHEA), 17beta-estradiol (E2), testosterone (T), and their sulfa
170 spensable for the atheroprotective action of 17beta-estradiol (E2), the main ligand of ERs.
171 roles in reproductive tissues--specifically, 17beta-estradiol (E2), the primary estrogen, which is se
172  decreases the conversion of testosterone to 17beta-estradiol (E2), thereby reducing E2-dependent vit
173 zed into 5alpha-dihydrotestosterone (DHT) or 17beta-estradiol (E2), which activate different hormonal
174 nism to facilitate auditory consolidation is 17beta-estradiol (E2), which is associated with human sp
175 least 17 CoRs from nuclear extracts bound to 17beta-estradiol (E2)-liganded estrogen receptor-alpha o
176 was decreased in bone in SPI-fed, but not in 17beta-estradiol (E2)-treated rats.
177 AR-dependent synaptic plasticity and memory, 17beta-estradiol (E2).
178 mouse responsive to long-term treatment with 17beta-estradiol (E2).
179 ironmental fate of steroid hormones, such as 17beta-estradiol (E2).
180 gnificantly correlated with plasma levels of 17beta-estradiol (E2).
181 -1)) sensitivity for the endocrine disruptor 17beta-Estradiol (E2).
182 l aromatase, which produces the neurosteroid 17beta-estradiol (E2).
183 ontributes to the neuroprotective effects of 17beta-estradiol (E2); however, the mechanisms associate
184 eak proestrus levels of the primary estrogen 17beta-estradiol (E2; 10 mug/kg, i.p., 1-h pretreatment)
185 tics), genistein (GEN; found in soybean), or 17beta-estradiol (E2; an endogenous estrogen).
186 erator-activated receptor gamma agonist) and 17beta-estradiol (E2; an estrogen receptor alpha agonist
187  distinct cellular signaling pathways (i.e., 17beta-estradiol [E2] and TNF-alpha).
188                      Elevations in estrogen (17beta-estradiol, E2) are associated with increased alco
189                 We have shown that estrogen (17beta-estradiol, E2) inhibits expression of these genes
190 pes) after exposure to two concentrations of 17beta-estradiol (E2beta; 2 ng/L and 50 ng/L) during fou
191 ively at an average concentration of 10 ng/l 17beta-estradiol equivalent (EEQ), 26 ng/l testosterone
192                          Results showed that 17beta-estradiol equivalent levels were higher than thos
193 ptor activities, with 13 surface waters with 17beta-estradiol-equivalent (E2Eq) activities greater th
194 ore the WWTP replacement, in vitro ER (24 ng 17beta-estradiol equivalents/L)-, GR (60 ng dexamethason
195                 Sex steroid hormones such as 17beta-estradiol (estradiol) regulate neuronal function
196 e estrogens included for study were estrone, 17beta-estradiol, estriol, 17alpha-ethinylestradiol, and
197                                 Signaling of 17beta-estradiol (estrogen) through its two nuclear rece
198                    Four steroidal estrogens (17beta-estradiol, estrone, estriol, and 17alpha-estradio
199                                     Although 17beta-estradiol has long been known to regulate memory
200                                              17beta-Estradiol improved microcirculatory perfusion and
201     Additionally, post-SCI administration of 17beta-estradiol improved skilled forelimb function and
202           Long-term cyclic administration of 17beta-estradiol improves working memory, and restores h
203 e selective detection of the water pollutant 17beta-estradiol in buffer and tap water.
204 me inexpensive and easy-to-use monitoring of 17beta-estradiol in environmental samples such as efflue
205 , whereas it mimics the protective action of 17beta-estradiol in other tissues such as arteries.
206 , showing the ability of detecting traces of 17beta-estradiol in serum at concentrations lower than t
207     We here report on the immunodetection of 17beta-estradiol in serum by antibody-immobilized microc
208 n castrated male mice, and IL-6 induction by 17beta-estradiol in splenocytes from naive female mice (
209  construct a voltammperometric biosensor for 17beta-estradiol in the 0.9-11 pM range.
210                     This study revealed that 17beta-estradiol in the brain mediated the physiological
211 et of seizures by promoting the synthesis of 17beta-estradiol in the brain.
212 ot only the expression of P450arom, but also 17beta-estradiol in the cerebral cortex.
213 s genomic/transcriptional) demonstrated that 17beta-estradiol-induced acceleration of endothelial hea
214 type 16 E6 and E7, short-term treatment with 17beta-estradiol induces CINs that progress to cervical
215                                              17beta-Estradiol is a multi-active steroid that imparts
216 4+CD25+FoxP3+ regulatory T-cells (Tregs) and 17beta-estradiol is crucial in the pathogenesis of sex b
217 lower threshold for synaptic plasticity when 17beta-estradiol is elevated.
218                                  The steroid 17beta-estradiol is known to acutely potentiate glutamat
219 thinyl estradiol (EE), a synthetic analog of 17beta-estradiol, is prescribed commonly and found in or
220                               Attenuation of 17beta-estradiol (k(stream) = -3.2 +/- 1.0 day(-1)) was
221 ensor surface, and a higher concentration of 17beta-estradiol leads to less fluorescence-labeled DNA
222                                              17beta-estradiol led to a significant upregulation in pe
223 utcomes were percent change from baseline in 17beta-estradiol levels (E2) and tricuspid annular plane
224     A P450arom inhibitor, letrozole, reduced 17beta-estradiol levels and completely suppressed the el
225 eceptor-dependent inhibition in females when 17beta-estradiol levels are elevated.
226 tolerance, and suggest approaches to restore 17beta-estradiol levels as a novel treatment option for
227 onbreeding conditions by manipulating plasma 17beta-estradiol levels in wild-caught female Gambel's w
228 n Cyp19a1 suppression, decreased circulating 17beta-estradiol levels, abnormal fat accumulation, and
229 elopment, and photoproducts alter whole-body 17beta-estradiol levels.
230 n in males, was positively related to plasma 17beta-estradiol levels.
231 (Cyp19a1) expression and reduced circulating 17beta-estradiol levels.
232 ial to influence the human daily exposure to 17beta-estradiol like activity in various risk groups wi
233  that treatment of postmenopausal women with 17beta-estradiol markedly enhances TLR-7- and TLR-9-depe
234          Thus, the anti-oxidative effects of 17beta-estradiol may be involved in the prevention of se
235 om naive female mice (p<0.05) suggested that 17beta-estradiol may enhance sex bias through IL-6 induc
236                              Osteocalcin and 17beta-estradiol mediate their effects through G protein
237                                              17beta-Estradiol-mediated enhancement of ethanol-induced
238                                              17beta-Estradiol mediates the sensitivity to pain and is
239 vitro culture of isolated uterine ILC2s with 17beta-estradiol modified expression of a number of gene
240 about the molecular mechanisms through which 17beta-estradiol modulates hippocampal memory.
241            The acute vasodilatory effects of 17beta-estradiol (non-specific estrogen receptor (ER) ag
242 itment to the cell cycle following strain or 17beta-estradiol occurs within 30 min, as determined by
243 stration of dexamethasone or prednisolone or 17beta-estradiol on Charolais bulls.
244 receptor (GPER) activation mimics effects of 17beta-estradiol on hippocampal memory consolidation.
245 characterize the effects of DHEA, prolactin, 17beta-estradiol on insulin-growth factor-1 and -2 (IGF-
246  to determine the molecular level effects of 17beta-estradiol on single MCF-7 cells using Fourier tra
247 DC lineage abrogated the enhancing effect of 17beta-estradiol on their TLR-mediated production of IFN
248                                  Delivery of 17beta-estradiol or an estrogen receptor (ER)-alpha (but
249 ranscriptional activity include the agonists 17beta-estradiol or conjugated estrogens with the antago
250  on proestrous morning, when serum levels of 17beta-estradiol peak, the nonspecific opioid receptor a
251  women with unopposed estrogen, we implanted 17beta-estradiol pellets in adult female Pten heterozygo
252 ng/ml E.coli flagellin (F) for 12 h, or 4 nM 17beta-estradiol plus 50 ng/ml flagellin (E + F(12 h)).
253 mice synchronized into estrus by delivery of 17beta-estradiol prior to intravaginal challenge with wi
254                                              17beta-estradiol production by LSCC cell lines UM-SCC-11
255 data suggest that post-SCI administration of 17beta-estradiol protected both the gray and white matte
256                               In conclusion, 17beta-estradiol protects osteocytes against apoptosis b
257  study, we elucidated the mechanism by which 17beta-estradiol regulates the transcription of SNAT2.
258                                              17beta-estradiol replacement in SERT (-/-) mice reversed
259  that the anti-apoptotic effects of cGMP and 17beta-estradiol required BAD phosphorylation on Ser(136
260                 Akt and ERK1/2 activation by 17beta-estradiol required PKG II, and cGMP mimicked the
261 CC cultures and xenografts were examined for 17beta-estradiol responsiveness in vivo.
262             The study provides evidence that 17beta-estradiol restores the tetramer-to-monomer ratio
263                             Coinjection with 17beta-estradiol resulted in a decrease in (18)F-FES upt
264             A structure of the ancestor with 17beta-estradiol revealed only one molecule in the activ
265 that maximal binding occurred at the highest 17beta-estradiol serum concentration.
266                                 In contrast, 17beta-estradiol significantly increased the abundance o
267             DHEA-sulfate (DHEA-S), DHEA, and 17beta-estradiol stimulated keratinocyte and fibroblast
268 g of each of these proteins nearly abolished 17beta-estradiol-stimulated SNAT2 promoter activity.
269 ith estrogen receptor alpha (ER-alpha) after 17beta-estradiol stimulation.
270     Ovariectomized females supplemented with 17beta-estradiol succumbed to P. aeruginosa challenge ea
271 sses seizures, focusing on the regulation of 17beta-estradiol synthesis in the brain.
272 estrogens (o-CEE), 0.45 mg/d, or transdermal 17beta-estradiol (t-E2), 50 mcg/d, each with 200 mg of o
273                     Here we demonstrate that 17beta-estradiol, tamoxifen, and fulvestrant induce nucl
274 tes with PMCA with or without treatment with 17beta-estradiol, thapsigargin, or G-1.
275                                  In animals, 17beta-estradiol (the major estrogen in most mammals, re
276                            When treated with 17beta-estradiol, the lipid utilization in cancer cells
277  with potential carcinogenic effects such as 17beta-estradiol, the most powerful substance with estro
278                                         Like 17beta-estradiol, the non-steroid Br-PBTC only requires
279 HED for the development of a brain-selective 17beta-estradiol therapy to relieve hot flushes without
280  and that transcript levels are modulated by 17beta-estradiol through the estrogen receptor (ER)alpha
281 how that a single intracerebral injection of 17beta-estradiol to ovariectomized female rats immediate
282 hoeae following treatment with water-soluble 17beta-estradiol to promote long-term gonococcal infecti
283 tion of VMH PI3K activity blocked effects of 17beta-estradiol to stimulate energy expenditure, but di
284 scriptional coregulator that is recruited by 17beta-estradiol to the promoters of estrogen target gen
285                                              17beta-Estradiol-treated ovariectomized female mice demo
286                                              17beta-Estradiol treatment was associated with 2-fold in
287  grow larger in vivo in response to systemic 17beta-estradiol treatments.
288  vertebra (C5) followed by administration of 17beta-estradiol via a slow release pellet (0.5 or 5.0 m
289 l squamous cell carcinoma (LSCC) responds to 17beta-estradiol via estrogen-receptor (ER, transcribed
290 ation reaction between 17alpha-estradiol and 17beta-estradiol via estrone was observed in aqueous sol
291                                              17beta-estradiol was detected below its quantitation lim
292 trone was detected in all of the samples and 17beta-estradiol was detected in one.
293                                              17beta-Estradiol was effective in improving mesenteric p
294                   The dose-response curve of 17beta-estradiol was established and a detection limit w
295 lipid synthesis in cancer cells treated with 17beta-estradiol was increased by 42%.
296                Coinjection of (18)F-FES with 17beta-estradiol was performed to determine whether trac
297                  For comparison, estrone and 17beta-estradiol were modeled and are likely capable of
298 mples containing different concentrations of 17beta-estradiol were premixed with a given concentratio
299 d as vitellogenesis-related and regulated by 17beta-estradiol were significantly enriched among those
300 These profound differences are influenced by 17beta-estradiol, which contributes both to T cell activ

 
Page Top